A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Clinical trial NCT04837131 · TERMINATED

Trial details

NCT number: NCT04837131
Sponsor: Michael M. Pham
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis Scleroderma Diffuse Systemic Sclerosis Diffuse Scleroderma Diffuse Cutaneous Systemic Sclerosis Diffuse Cutaneous Scleroderma Progressive Systemic Sclerosis Progressive Scleroderma Scleroderma, Systemic Scleroderma, Diffuse Scleroderma;Progressive Systemic Sclerosis, Diffuse

Start date: 2021-04-28
Primary completion: 2024-02-23
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.